You just read:

Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

News provided by

Novo Nordisk

23 Jun, 2018, 15:12 BST